WST NYSE
West Pharmaceutical Services, Inc.
1W: +2.9%
1M: +6.6%
3M: +17.3%
YTD: +43.0%
1Y: +28.6%
3Y: +7.6%
5Y: -2.3%
$398.29
+3.56 (+0.90%)
After Hours: $377.71 (-20.58, -5.17%)
Weekly Expected Move ±2.9%
$370
$381
$392
$403
$415
Credit Risk of going bust: lower than 93% of companies Debt: 1.1% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.34 (down 99.9%), West Pharmaceutical Services, Inc. would be worth roughly what it owes.
Total debt $312.1M against a stock market value of $27.78B.
Distance to default 16.41 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $166.5M (short-term plus half of long-term), stock volatility 31.4%; Altman Z 18.65. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.34 (down 99.9%), West Pharmaceutical Services, Inc. would be worth roughly what it owes.
Total debt $312.1M against a stock market value of $27.78B.
Distance to default 16.41 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $166.5M (short-term plus half of long-term), stock volatility 31.4%; Altman Z 18.65. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.00
Neutral
0 bullish
1 neutral
0 bearish
Articles (24h)
1
Hourly Sentiment (24h)
0.45
Bullish
1 bullish
1 neutral
0 bearish
Articles (7d)
2
Daily Sentiment (7 Days)
Articles (100)
WST Q3 Earnings Preview: Will HVP Strength Offset Vantage Weakness?
Reasons to Add West Pharmaceutical Stock to Your Portfolio Now
West Pharmaceutical declares $0.26 dividend
West Pharmaceutical Stock Gains 36.1% YTD: What's Behind the Rally?
West Pharmaceutical Services (NYSE:WST) Stock Price Crosses Above Two Hundred Day Moving Average – Time to Sell?
Veeva Systems' Basics Gains Traction With 175+ Emerging Biotech Firms
ANGO Q1 Earnings Beat Estimates on Med Tech Growth, Revenues Up Y/Y
Reasons to Hold Veeva Systems Stock in Your Portfolio for Now
Smith+Nephew Launches CARTIHEAL Implant Across Key European Markets
Here's Why You Should Retain WAT Stock in Your Portfolio for Now
West to Host Third-Quarter 2026 Conference Call
Reasons to Retain Fresenius Medical Stock in Your Portfolio for Now
BDX Expands U.S. Manufacturing With $19B Healthcare Investment
Reasons to Hold HealthEquity Stock in Your Portfolio for Now
Veeva's DQS Scales Data Automation Across 1,000+ Clinical Studies
2,020 Shares of West Pharmaceutical Services, Inc. $WST Acquired by Central Pacific Bank Trust Division
Here's Why You Should Add Merit Medical Stock to Your Portfolio Now
GE HealthCare Expands U.S. PET Radiopharma Reach With SOFIE Deal
Reasons to Retain Cardinal Health Stock in Your Portfolio for Now
Reasons to Retain Doximity Stock in Your Portfolio for Now
Veeva's OpenData to Help Servier Build a Global AI Data Foundation
Inspire Medical Gains New CPT Codes for Hypoglossal Nerve Stimulation
Smith+Nephew Launches EVOS PELVIC System to Advance Trauma Care
Here's Why You Should Retain Integer Holdings Stock in Your Portfolio
Here's Why You Should Retain BDX Stock in Your Portfolio for Now
Stock futures under pressure after Trump rejects Iran ceasefire proposal
Veeva Unveils AI Study Builder Agent to Speed Clinical Trial Setup
Here's Why You Should Retain Glaukos Stock in Your Portfolio for Now
Veeva Unveils Falcon Router to Streamline Biopharma Case Routing
Astrana is latest U.S. healthcare company to face acyberattack
State Street Corp Acquires 54,920 Shares of West Pharmaceutical Services, Inc. $WST
Here's Why You Should Retain IRTC Stock in Your Portfolio for Now
Reasons to Hold Hinge Health Stock in Your Portfolio for Now
Healthcare stocks with the strongest dividend growth grades
Avantor Broadens RIM Single-Use Bioprocessing Reach in APAC
Reasons to Add West Pharmaceutical Stock to Your Portfolio Now
Beta Bionics Stock Surges on FDA Clearance for Mint Patch Pump
Here's Why You Should Hold Solventum Stock in Your Portfolio for Now
Stock futures point higher as Fed delivers rate hike
Here's Why You Should Add Avantor Stock to Your Portfolio for Now
ISRG Wins EU Nod to Expand da Vinci SP in Gynecologic Procedures
Here's Why You Should Add BrightSpring Stock to Your Portfolio Now
BDX Deploys Vmax 160 to Advance Intelligent Pharmacy Automation
ISRG's da Vinci Study Shows Better Outcomes Across 13 Common Conditions
Here's Why You Should Retain DexCom Stock in Your Portfolio for Now
BLCO Gains European CE Mark for Next-Gen SeeLyra Femtosecond Laser
Notable healthcare headlines for the week: UnitedHealth, Amgen, and CooperCompanies in focus
Revvity to Acquire Human Cell Design to Boost Metabolic Discovery
IceCure Secures China NMPA Approval for ProSense Cryoablation System
Here's Why You Should Retain Ecolab Stock in Your Portfolio Now
COO Q3 Earnings Top Estimates, Revenues Miss on Destocking, Stock Down
West Pharmaceutical Services, Inc. $WST Shares Sold by HB Wealth Management LLC
Here's Why You Should Retain DaVita Stock in Your Portfolio for Now
GE HealthCare Moves StarGuide GX 4D SPECT/CT Toward FDA Clearance
The Cooper Companies Gears Up to Post Q3 Earnings: What's in Store?
PACS Expands Florida Footprint With 32-Facility Acquisition
Here's Why You Should Retain AMN Stock in Your Portfolio for Now
Nyxoah Stock Down Despite First Genio Implant in U.S. BREATHE Trial
Philips Expands Women's Health Ultrasound Portfolio With New Transducer
Novocure Reports Patient Data Exposure in Cybersecurity Incident
Here's Why You Should Retain Cencora Stock in Your Portfolio for Now
Reasons to Hold HealthEquity Stock in Your Portfolio for Now
Philips Shares AI Tool Data for Mitral Regurgitation Assessment at ESC
Here's Why You Should Retain NeuroPace Stock in Your Portfolio for Now
Cencora Launches Cell and Gene Therapy Enablement for Health Systems
Reasons to Hold Veeva Systems Stock in Your Portfolio for Now
Stryker Launches FDA-Cleared Apple Vision Pro Surgical App
Reasons to Retain Fresenius Medical Stock in Your Portfolio for Now
Reasons to Retain Hims & Hers Stock in Your Portfolio for Now
Enovis Boosts Surgical Robotics Portfolio With eCential Acquisition
Here's Why You Should Add Merit Medical Stock to Your Portfolio Now
GEHC Wins CE Mark for Photonova Spectra, Expands International Reach
Stryker to Acquire ZuriMED to Expand Its Shoulder Care Portfolio
Benjamin Edwards Inc. Grows Position in West Pharmaceutical Services, Inc. $WST
TXG Stock Down Despite Patent Verdict Win Against Parse Biosciences
GE HealthCare Unveils Next-Gen Vivid Cardiac Ultrasound Systems
West Pharmaceutical Services, Inc. (NYSE:WST) Receives Average Recommendation of “Moderate Buy” from Brokerages
7,730 Shares in West Pharmaceutical Services, Inc. $WST Bought by Caisse de depot et placement du Quebec
Canada Pension Plan Investment Board Buys Shares of 23,070 West Pharmaceutical Services, Inc. $WST
CVRx Secures Devoted Health Coverage for Barostim Therapy
Why Is Align Technology (ALGN) Down 8.4% Since Last Earnings Report?
Natera & Angiex Partner to Evaluate AGX101 Response With Signatera
Veeva Systems Q2 Earnings and Revenues Beat Estimates, Stock Up
McKesson to Acquire Precision Medicine Group to Strengthen Services
DVA & Humana Expand Value-Based Care for Kidney Disease Patients
Here's Why You Should Retain McKesson Stock in Your Portfolio for Now
Bausch + Lomb Advances Two First-in-Class Eye Health Therapies
Reasons to Retain Doximity Stock in Your Portfolio for Now
Reasons to Retain Cardinal Health Stock in Your Portfolio for Now
AMN Stock Rallies Nearly 119% YTD: What's Behind the Momentum?
Here's Why You Should Add GEHC Stock to Your Portfolio for Now
Here's Why You Should Retain OPK Stock in Your Portfolio for Now
3,700 Shares in West Pharmaceutical Services, Inc. $WST Purchased by Barbara Oil Co.
Advisors Capital Management LLC Acquires New Shares in West Pharmaceutical Services, Inc. $WST
Here's Why You Should Retain Inogen Stock in Your Portfolio for Now
Johnson & Johnson Wins FDA 510(k) Clearance for MONARCH QUEST 3 Update
INSP Stock Rallies Nearly 40% YTD: Can Its Growth Story Continue?
BrightSpring Stock Up Nearly 59% YTD: Can Its Growth Story Continue?
Here's Why You Should Hold Stryker Stock in Your Portfolio for Now
BDX Completes PREVENT Trial Enrollment for Phasix Mesh Study